- When not to perform dissolutions
- Validation on ER Tablets
- Method Development Dearation Set-Up
- Waiver of In-vivo Bioavailability and Bioequivalence Studies
- Calibration Curve
- Method Development Dissolution results in higher side
- Regulatory Discussion Multimedia Dissolution
- Anyone have dissolution presentation?
- Dissolution Theory Reciprocating Cylinder (USP-III)
- Regulatory Discussion Profile similarity
- dissolution media for Extended release
- Calibration fixed positions for vessels?!!
- Method Development simultaneous analysis of Metformin and Glimepiride in dissolution samples by HPLC
- Using sinker in the dissolution of carvedilol tablets
- Method Development Bupropion HCl dissolution hiher side
- General Lysine Acetylsalicylate Analytical Methodology
- Dissolution Theory Sample protocol
- Method Development Simulated intestinal fluid
- Method Development Dissolution Medium for glimepiride /metformin HCl combination tablets
- Dissolution Behavior of Microcrystalline Cellulose
- Regulatory Discussion Dissolution sampling
- Dissolution Theory diffrent dosage form
- S.o.s
- Apparatus 7
- Dissolution Testing - Future
- Please help
- General Powder dissolution with USP IV
- Method Development different baskets
- Validation Er tablets - method precision
- A simple QC approach
- General Enzyme Conversion unit
- Solubility determinations
- Method Development Transdermal Systems-Selection of media/volume
- F2 evaluation and BE possibility
- Apparatus 4
- Dissolution media for poorly solble drugs
- Method Development Oil Soluble vitamins
- General Dissolution method for voglibose
- Pantoprazole E/C Tab dissolution
- Calibration Mechanical calibration
- Method Development In-Vitro release for suspensions
- Dissolution Theory Fixing of specification limit in dissolution
- General Dissolution method development
- General Number of time points for a dissolution profile
- General Dissolution Method Change
- New change to pvt
- Tacrolimus
- Method Development Franz diffusion
- Sublingual tablets
- Dissolution Theory Cholecalciferol(Vitamin D3) Dissolution method
- Method Development Delayed release systems
- General USP requirement for sinkers
- pH of hydrogel transdermal system
- Calibration FIP position concerning FDA draft guidance for mechanical calibration
- Dissolution Problem in LOsartan + Hydrochlorothiazide Tablet
- Method Development amtolmetin
- Dissolution Theory prodrug
- General selecting of franz cell membrane
- Method Development Dissolution of Practically insoluble drug
- Itraconazole Dissolution
- Troubleshooting Effect of RPM on Extended Release
- Dissolution Theory nitaxozanide disolution
- Calibration MQ testing
- Limit for start the test
- Dissolution Media
- Method Development Telmisartan/Hydrochlorothiazid
- General Use of Organic Solvent in dissolution medium
- Method Development Rational use of Sinkers
- General Dissolution Method
- Method Development What flow rate and time interval usually used for slow release drug using USP 4
- New Revelation
- Method Development Excipients trapped inside baskets @ 50 rpm’s
- Regulatory Discussion Dissolution rate calculation: based on label claim or assay?
- Apparatus 3 calibration using 1L vessels?
- Assay procedures for vitamins
- Method Development Haziness of Phosphate Buffers
- Method Development Dissolution medium for Rabeprazole Delayed Release Tablets
- General Dissolution Standard preparation
- Placebo Effect Getting Stronger
- Dissolution for 4 weeks
- Regulatory Discussion Functional Coating weight gain not weight proportional
- Troubleshooting Lansoprazole dissolution and degradation
- The dissolution method of tab contain Papaverine, Metamizole, Belladonne
- enzimes in Eu.Pharm.
- Dissolution Theory monograph tolerance limit of irbesartan dissolution
- Method Development Dissolution of Valsartan Immediate release Tablets
- Poorly soluble capsules
- Troubleshooting Tablets dissolution rate slow down over time?
- General Biorelevant medias / Physiological mediums
- Calibration status of the mechanical check
- Phosphate or Acetate buffer pH 4.5
- SLS inhibits Enzyme?
- General Quetiapine extended release tablet
- Transit time in Small intestine and medium
- Validation Validating the range of a method
- Dissolution Theory HPC Role in Dissolution media
- Method Development App 7 with OE Tablets
- Maximum Limits for Surfactant in Dissolution Media
- Quetiapine and solubility class
- Calibration Mechanical Calibration
- Choose of mediums for comparative dissolution profiles (f2)
- Acetate Buffer as dissolution media
- Cyclosporine A Dissolution Medium
- validation of Tier II method
- Troubleshooting Lipidic semisolid formulation
- Troubleshooting Variables in the dissolution results
- Validation Intermediate precision - modified release
- dissolution with SGF
- When to use disintegration disks
- Tris Buffer pH 4.0
- Nifuroxazide
- Metformin baskets
- Regulatory Discussion Target Dissolution Rate for Extended Release Dosage Forms
- General Degradation in certain recomended media during dissolution comparative studies
- General Coning Effect issues on biorelevant medium
- Sink conditions with surfactants
- Media incompatibility
- Regulatory aspects- Atorvastatin
- Cameras for monitoring automated runs
- Lacticin by HPLC
- Calibration Salicyclic acid PVT
- Basket Integrity verification
- App 5 or Ring/Mesh with Small Volume Dissolution?
- Method Development Extended release development
- Method Development Drug release: subcut implant
- Which Calibration Type are you using?
- Method Development Re-crystallization / precipitation of API during dissolution test.
- Method Development Does Pancreatin precipitate with SLS
- media for Glyburide in Metformin+Glyburide
- Mishapen/damaged baskets
- Automated degassing
- dissolution for injectable suspensions
- Method Development Dissolution media clarification
- Formation of chelates help me...
- Sampling procedure for apparatus 6 (cylinder)
- Regulatory Discussion dissolution comparison for suppositories
- controlled release tablet dosage form
- Disposal of dissolution medium
- Dissolution Theory Pantoprazol sodium Enteric Coated Tablet Dissolution
- Dissolution Theory SLS and Biorelevant Properties for Thiocolchicoside
- Level A IVIVC for biphasic product
- Dissolution testing for IR in oil formulation
- Tier 2 dissolution medium pH with pepsin
- General Manual Sampling: Fresh syringe filter each time-point or one for each Vessel?
- Non-standard dissolution media: HEPES and MOPS
- General Oral Suspensions
- Dissolution Theory Maximum level of SLS in diso media???
- Regulatory Discussion Changes to the Dissolution Performance Verification test
- Batch size for IVIVC development
- assay limit acc to ICH guideline
- F2 value and ANDA submission
- Using Paddle over disk method for Tablets
- Method Development Citro phosphate buffer
- FDA's January 2010 Guidance on bath Calibration
- Validation Diss. Method Re-validation
- enzyme and soft gelatin capsules
- Programming for Autosampling
- Regulatory Discussion Changing disso medium
- salt precipitation in my PBS buffer
- Early time point > 100 % - Filtration issue
- Usage of sinkers for IR tablet formulation
- Dissolution of Phenylephrine and Terfenadine
- Regulatory Discussion Omeprazole (Prilosec) and BCS
- Eudragit NE
- General TRUE Borelevant dissolution medium/dissolution condition
- Troubleshooting Impact of Magnesium oxide on drug release upon storage
- Dissolution Theory 3 media disolution for Class 1 molecule
- Regulatory Discussion New EMEA guidelines BA/BE
- Dissolution Theory Minimum requirement for Dissolution
- General Disintegration testing of novel dosage form
- PVT - Calculation Tool
- Total dissolved gas pressure meter
- Method Development Modified Release Tablets
- Method Development Cutting caplet for dissolution
- Very high CV for Fast dissolving tablet
- Database Corruption / Missing Posts & Registrations
- Calibration Are basket and paddle position important?
- Troubleshooting Dissolution media degasing for extended release formulation dosage form
- Dissolution Theory Model Independent multivariate confidence region procedure
- different types of dissolution medium
- Method Development Reciprocating Cylinder - Apparatus III
- Method Development pramipexole
- change of mesh size in basket for dissolution
- Regulatory Discussion Data to support a request for Biowaiver
- Non Ionic Surfactants?
- Regulatory Discussion Drug Stability and Comparative in vitro Dissolution